M. Gore

3.2k citations

94 papers · 2.4k indexed · h-index 29

Reproductive Medicine top 1%
- Ovarian cancer diagnosis and treatment 21
Oncology top 2%
- Cancer Immunotherapy and Biomarkers 7
Obstetrics and Gynecology top 5%
Pulmonary and Respiratory Medicine top 5%
- Renal cell carcinoma treatment 31
Pathology and Forensic Medicine top 5%
- Lymphoma Diagnosis and Treatment 9
Cancer Research
- Cancer Genomics and Diagnostics 17
Economics and Econometrics
- Economic and Financial Impacts of Cancer 14
Surgery
- Intraperitoneal and Appendiceal Malignancies 8
Molecular Biology
- Melanoma and MAPK Pathways 7

Co-authors: Roger A’Hern J. Moore Timothy Perren Jean‐Paul Guastalla G. Favalli Ángel J. Lacave Giorgio Bolis Giovanna Scarfone
Cited by: Reproductive Medicine Oncology Obstetrics and Gynecology
Journals: Journal of Clinical Oncology (32 papers)British Journal of Cancer (19 papers)Annals of Oncology (10 papers)
Partner nations: United Kingdom United States Netherlands

In The Last Decade

M. Gore

92 papers receiving 2.3k citations

Peers

Countries citing papers authored by M. Gore

Since Specialization

Citations

This map shows the geographic impact of M. Gore's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Gore with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Gore more than expected).

Fields of papers citing papers by M. Gore

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Gore. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Gore. The network helps show where M. Gore may publish in the future.

Co-authorship network

The 25 scholars most cited alongside M. Gore, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with M. Gore Line = papers co-authored together M. Gore links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	A study of the decision outcomes and financial costs of multidisciplinary team meetings (MDMs) in oncology British Journal of Cancer ·豪小笠原,Jermaine Coward,Ricardo Rocha de Oliveira,Ulrike Schick,Meera Nandhabalan,Sophia Frentzas,M. Gore	2013	68
2	Clinical response to ipilimumab: Effect of systemic corticosteroids used to manage immune-related adverse events (irAEs) Annals of Oncology ·Paul Lorigan,Jeff Sosman,J.B.A.G. Haanen,Jose Lutzky,David Hogg,M. Gore,W J Urba,Veerle de Pril,A. Borghetti,J. D. Wolchok	2010	5
3	Costs of managing adverse events in the treatment of first-line metastatic renal cell carcinoma: bevacizumab in combination with interferon-α2a compared with sunitinib British Journal of Cancer ·G. Mickisch,M. Gore,Bernard Escudier,Giuseppe Procopio,Stefan Walzer,Mark Nuijten	2009	54
4	EORTC Melanoma Group. Adjuvant therapy with pegylated interferon alfa-2b versus observation alone in resected stage III melanoma: final results of EORTC 18991, a randomised phase III trial. The Lancet ·Eggermont Am,Stefan Suciu,Mario Santinami,Alessandro Testori,闫璨,J.R. Marsden,Feng Jiang,François Salès,M. Gore,Rahimi Ahmad Mustafa,Zvonko Kusić,Reinhard Dummer,Axel Hauschild,Paul Lorigan,E. Musat,Alan Spatz,Ulrich Keilholz	2008	77
5	A Novel Point Mutation in P450c17 (CYP17) Causing Combined 17α-Hydroxylase/17,20-Lyase Deficiency The Journal of Clinical Endocrinology & Metabolism ·Antonia Brooke,Norman Taylor,J. H. Shepherd,M. Gore,T. Ahmad,Liang‐In Lin,Gill Rumsby,Mahboubeh Papari-Zareei,Richard J. Auchus,John C. Achermann,John P. Monson	2006	34
6	The current status of interferon‐α treatment in advanced renal cancer British Journal of Urology ·Justin Stebbing,M. Gore	2001	8
7	Dacarbazine, cisplatin and IFN-alpha with or without IL-2 in advanced melanoma (EORTC trial 18951) Annals of Oncology ·Ulrich Keilholz,C.J.A. Punt,M. Gore,闫璨,Payal T. Patel,D. Liénard,A. van Oosterom,Thomas M. Proebstle,A.M.M. Eggermont	2000	15
8	A new standard of care for treatment of ovarian cancer European Journal of Cancer ·Martine Piccart,Andreas du Bois,M. Gore,J.P. Neijt,S. Pecorelli,Éric Pujade-Lauraine	2000	24
9	Phase III trial of modulation of cisplatin/fluorouracil chemotherapy by interferon alfa-2b in patients with recurrent or metastatic head and neck cancer. Head and Neck Interferon Cooperative Study Group. Journal of Clinical Oncology ·D. Schrijvers,Jonas T. Johnson,Luisa Morelli,M. Gore,P. Kosmidis,H Szpirglas,K. Thomas Robbins,William T. Coolahan,Rolf Lewensohn,J. Schüller,A. Riviére,P. Hiismaeki,P. Langecker,Elvira Rodríguez,Esteban Cvitkovic,Everett E. Vokes	1998	53
10	Outcome assessment of a population-based group of 195 unselected myeloma patients under 70 years of age offered intensive treatment Bone Marrow Transplantation ·R Powles,Noopur Raje,S Milan,B. C. Millar,V Shepherd,Minesh P. Mehta,Seema Singhal,S Kulkarni,C. Viner,M. Gore,David Cunningham,J Treleaven	1997	55
11	A phase I/II study of leucovorin, carboplatin and 5-fluorouracil (LCF) in patients with carcinoma of unknown primary site or advanced oesophagogastric/pancreatic adenocarcinomas British Journal of Cancer ·Anne Rigg,David Cunningham,M. Gore,Mark Hill,Mary O’Brien,M. Nicolson,Joon Chang,Maggie Watson,A. Norman,A Hill,J. Oates,Halle C. F. Moore,Paul J. Ross	1997	12
12	The significance of paracardiac lymph node enlargement in ovarian cancer Clinical Radiology ·B. Holloway,M. Gore,Roger A’Hern,Igor Biłous	1997	48
13	Phase I trial and tumour localisation of the anti-EGFR monoclonal antibody ICR62 in head and neck or lung cancer British Journal of Cancer ·Helmout Modjtahedi,Tamas Hickish,Margery Nicolson,J. Moore,Cecilia Valdivia Silva,S. A. Eccles,Phillippi M.A.,Janine Salter,John Sloane,Loreto Spencer,K. Priest,Isabel Smith Zubiaga,Christopher Dean,M. Gore	1996	82
14	‘Tomudex’ (ZD1694) : A novel thymidylate synthase inhibitor with clinical antitumour activity in a range of solid tumours Annals of Oncology ·David Cunningham,John Zalcberg,I E Smith,M. Gore,Richard Pazdur,Howard A. Burris,N J Meropol,Gerard T. Kennealey,Leonard W. Seymour	1996	45
15	Transformation of residual mature ovarian teratoma to adenocarcinoma 10 years after initial treatment Clinical Oncology ·Marwa Mahmoud,M. Gore,J. H. Shepherd,Cyril Fisher	1996	5
16	Paclitaxel (Taxol) in relapsed and refractory ovarian cancer: the UK and Eire experience British Journal of Cancer ·M. Gore,Vincent Lévy,Gordon Rustin,Timothy Perren,A H Calvert,Helena Earl,JM Thompson	1995	45
17	Evaluation of the efficacy of the VEEP regimen in adult Hodgkin's disease with assessment of gonadal and cardiac toxicity. Journal of Clinical Oncology ·Mark Hill,S Milan,David Cunningham,Janine Mansi,Ian Smith,Daniel Catovsky,M. Gore,Ren Xu-ka,Peter Selby,Alan Horwich	1995	37
18	The treatment of metastatic renal cell carcinoma by continuous intravenous infusion of recombinant interleukin-2 European Journal of Cancer ·M. Gore,Enzo Galligioni,C.W. Keen,Roberto Sorio,Denise Aron-Schröpfer,Takatomi,C.R. Franks	1994	19
19	Phase II trial of trimelamol in refractory ovarian cancer British Journal of Cancer ·Yin Men,A H Calvert,M. Gore,Kathryn Balmanno,Walaa Abdelaziz Tageldin Elbashir,Timothy Perren,E. Wiltshaw	1991	8
20	A PHASE-I HIGH-DOSE ESCALATION STUDY OF CARBOPLATIN UCL Discovery (University College London) ·M. Gore,AH Calvert,IE Smith	1987	3

About M. Gore

M. Gore is a scholar working on Reproductive Medicine, Oncology, Cancer Research, Pulmonary and Respiratory Medicine and Obstetrics and Gynecology, having authored 94 papers that have together received 2.4k indexed citations. Recurring topics across this work include Renal cell carcinoma treatment (31 papers), Ovarian cancer diagnosis and treatment (21 papers), Cancer Genomics and Diagnostics (17 papers), Economic and Financial Impacts of Cancer (14 papers), Lymphoma Diagnosis and Treatment (9 papers), Intraperitoneal and Appendiceal Malignancies (8 papers), Melanoma and MAPK Pathways (7 papers) and Cancer Immunotherapy and Biomarkers (7 papers). The work is most often cited by research in Reproductive Medicine (503 citations), Oncology (1.1k citations), Obstetrics and Gynecology (214 citations), Pulmonary and Respiratory Medicine (609 citations) and Pathology and Forensic Medicine (285 citations). M. Gore has collaborated with scholars based in United Kingdom, United States and Netherlands. Frequent co-authors include Roger A’Hern, J. Moore, Timothy Perren, Jean‐Paul Guastalla, G. Favalli, Ángel J. Lacave, Giorgio Bolis, Giovanna Scarfone, I Hudson and Jaap Verweij. Their work appears in journals such as Journal of Clinical Oncology, British Journal of Cancer, Annals of Oncology, European Journal of Cancer and Value in Health.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact